Measuring autophagy level along with vaccine reactive IFN-γ+CD4+ Th1 cells may be a promising approach to understand efficacy of anti TB vaccine(s)
Journal Title: Journal of Vaccines and Immunology - Year 2018, Vol 4, Issue 1
Abstract
Autophagy is a homeostatic process in the eukaryotic cells which contributes towards degradation of unwanted cellular constituents, killing of the invading intracellular microbes and generation of cell mediated immunity (CMI). The professional antigen presenting cells (APCs) like: macrophages and dendritic cells, present microbial antigens (derived from engulfed and killed microbe) in combination with MHC-II to generate IFN-γ producing CD4+ Th1 cells. Over the years, inducing IFN-γ+ CD4+ Th1 mediated CMI has remained, predominantly, as the target for developing anti TB vaccine. In individuals, where Mycobacterium tuberculosis (MTB) bacilli invading the APCs evade induction of autophagy, anti TB vaccine may not be effective due to lack of presentation of MTB derived antigens to generate and re-stimulate vaccine generated memory CD4+ Th1 cells. On the other hand, induction of autophagy in the APCs kills the invading MTB bacilli and may sufficiently present microbial antigens to generate and re-stimulate vaccine generated IFN-γ producing CD4+ Th1 memory cells. The re-stimulated memory cells then differentiate to effector CD4+ Th1 cells to release IFN-γ which further takes part in activation of antimicrobial activity in APCs thereby leading to protection of the vaccinees and sustaining the vaccine generated CMI. Keeping all these points in view, a hypothesis has been described here, wherein it has been suggested that measuring autophagy activation status in combination with prevalence of IFN-γ producing memory/effector CD4+ Th1 cells against vaccine antigens may prove to be promising biomarkers for assessing protective efficacy of anti TB vaccine(s).
Authors and Affiliations
Parkash Om
Keywords
Related Articles
- EP ID EP553763
- DOI 10.17352/jvi.000022
- Views 64
- Downloads 0
IMS 4112 and VLP of HBV as Th1 Adjuvants for a Recombinant Protein of HIV-1
Background: Current thinking suggests that vaccination approaches against the HIV-1 should be directed to elicit a Th1 cell-mediated immunity, neutralizing antibodies and/or ADCC mediating antibody responses. Also, exper...
Mild Encephalitis/Encephalopathy with a Reversible Splenial Lesion Associated with Rhinovirus Infection
We report a 7-year-old patient with mild encephalopathy with a reversible splenial lesion (MERS) presenting with recurrent delirious behavior, hallucinations and seizures following common cold. Cranial MRI showed high si...
Prospects for the Development of a Dengue Vaccine
Dengue is a mosquito-borne viral disease which is currently an important and rapid growing health problem across the globe. Four closely related dengue serotypes cause the disease, which ranges from asymptomatic infectio...
Construction of Indonesian-Strain Avian Flu Virus Seed Vaccine Using Low Pathogenic Hemagglutinin Gene and Neuraminidase Pr8 Gene through Reverse Genetics
Avian Influenza H5N1 has been spreading in Indonesia since 2003. The Avian influenza virus H5N1 actually infects various animals, including birds, mammalian and others. Since 2005, avian influenza virus has infected huma...
Safety of the Novel Vector Vaccine Against Brucella Abortus Based on Recombinant Influenza Viruses Expressing Brucella L7/L12 and OMP16 Proteins, in Cattle
This paper presents the results of a study of the safety of new vector vaccine against B. abortus based on recombinant influenza A subtype H5N1 or H1N1 (viral constructs vaccine formulation) viruses expressing Brucella r...